UChicago Medicine

https://www.uchicagomedicine.org/

 

UChicago Medicine
Avatar

COVID-19, HSCT & CAR T Therapy: What Are the Potential Disruptions to Resources?

By UChicago Medicine FEATURING Michael Bishop
By UChicago Medicine FEATURING Michael Bishop
48 views
May 7, 2020
1 Comment
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
COVID-19
14:08
UChicago Medicine

COVID-19 and Gastrointestinal Manifestations

Feat. M. Elias
08:40
UChicago Medicine

COVID-19: Organ Manifestations

Feat. M. Kumar
15:17
UChicago Medicine

Cardiac Sequelae of SARS-CoV-2 and COVID-19 in the Pediatric Populat…

Feat. S. Basu
15:37
UChicago Medicine

COVID-19 and Allergy

Feat. S. Handoyo
67:42
UChicago Medicine

Hematopoietic Stem Cell Transplantation and CAR T-cell Therapy Durin…

Feat. M. Bishop
10:57
UChicago Medicine

COVID-19, HSCT & CAR T Therapy: What Are the Potential Disruptio…

Feat. M. Bishop
27:21
UChicago Medicine

COVID-19, HSCT & CAR T Therapy: How Does the Pandemic Effect Upo…

Feat. M. Bishop
26:12
UChicago Medicine

COVID-19, HSCT & CAR T Therapy: Which Patients Are Appropriate f…

Feat. M. Bishop